Riskpilot← Back to searchSign inGet full accessSALMOSEED AS
ASActiveOrg 922273057Lerstadvegen 250, 6014 ÅlesundEconomic activity was not specified by tax authority · NACE 0000Est. 20190 employees
Revenue 2024
NOK 0
EBITDA margin
—
-76% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -452K
-168% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -43K | -76% |
| Net profit | NOK -452K | -168% |
| Total assets | NOK 792K | -37% |
| Equity | NOK 792K | -36% |
| Employees | 0 | — |
Legal name
SALMOSEED AS
Org number
922273057
Legal form
Aksjeselskap
NACE code
0000 · Economic activity was not specified by tax authority
Founded
26. februar 2019
Share capital
NOK 949 450
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investering i virksomhet innenfor akvakultur, herunder aksjer og andeler, samt deltagelse i andre selskaper med virksomhet innenfor tilsvarende næring.
Address
Lerstadvegen 250, 6014 Ålesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −399 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −424 | −18 | −17 | −14 | −25 | −43 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −424 | −18 | −17 | −14 | −25 | −43 |
| Net financials | −0 | 0 | 0 | 0 | 685 | −299 |
| Profit before tax | −424 | −18 | −17 | −14 | 660 | −342 |
| Tax | −93 | −4 | −4 | −3 | −5 | 110 |
| Net profit | −331 | −14 | −13 | −11 | 666 | −452 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 587 | 602 | 589 | 587 | 1 248 | 792 |
| Equity | 517 | 602 | 589 | 578 | 1 244 | 792 |
| Long-term debt | 70 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 9 | 4 | 0 |
| Total debt | 70 | 0 | 0 | 9 | 4 | 0 |
EBITDA margin
-4346300.0%
This company
15.8%
Market median
-27508328% vs market
20192024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20192024
Return on equity
-57.0%
This company
18.4%
Market median
-410% vs market
20192024
Net profit margin
-45180800.0%
This company
8.1%
Market median
-557787754% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20192024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GA Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Gb Value As | Company | 50.1% | 50.1% | 2022 |
Prophylaxia As | Company | 23.3% | 23.3% | 2022 |
Salmoserve As | Company | 10.8% | 10.8% | 2022 |
Torino As | Company | 8.7% | 8.7% | 2022 |
Larsnes Mek Verksted As | Company | 7.1% | 7.1% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Gb Value As
SALMOSEED AS Board members of SALMOSEED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Glen Allan Bradley | Chief Executive Officer | 0 companies |